The article is available online from Trends in Biotechnology. A preprint is also available from BioRxiv. GenoFAB is a synthetic biology platform dedicated to helping life scientists write and ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

There is a consistent need from researchers to manufacture a cGMP virus to support the advancement of gene therapies.

Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in BioTech and Digital Health.

is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in biotech and digital health. Angelini Ventures will invest €300 million across a global ...

Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in BioTech and Digital Health.

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles. While many countries have seen a decline in investment in recent years ...

The Swiss Biotech Report 2025 has indicated that R&D investment in Switzerland increased in 2024, compared to 2023.

The article is available online from Trends in Biotechnology. A preprint is also available from BioRxiv. GenoFAB is a synthetic biology platform dedicated to helping life scientists write and debug ...